MedWell Laboratories Overview

  • Founded
  • 2009
Founded
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

MedWell Laboratories General Information

Description

Developer of non-steroidal anti-inflammatory drugs. The company develops non-steroidal anti-inflammatory drugs for treatment of mild to moderate chronic inflammatory disorders. It develops drug which are effective and safe due to the mechanism of action as cyclooxygenase 2 (COX-2) and 5-Lipoxygenase (5-LOX) enzymes dual inhibition.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • Nazareth Industrial Area
  • P.O. Box 2252
  • Nazareth 16000
  • Israel
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

MedWell Laboratories Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Oct-2017 Completed Out of Business
1. Accelerator/Incubator Completed Startup
To view MedWell Laboratories’s complete valuation and funding history, request access »

MedWell Laboratories Executive Team (2)

Name Title Board Seat Contact Info
Michal Olshansky Chief Executive Officer
Taher Nassar Ph.D Co-Founder, Inventor, Board Member & Chief Scientist
To view MedWell Laboratories’s complete executive team members history, request access »

MedWell Laboratories Board Members (3)

Name Representing Role Since
Nasri Said MedWell Laboratories Chairman 000 0000
Oren Fuerst Ph.D Self Board Member 000 0000
Sheila Oren MD Self Board Member 000 0000
To view MedWell Laboratories’s complete board members history, request access »